Long-term Cognitive and Functional Status After COVID-19 Treatment at Danish ICUs
1 other identifier
observational
203
1 country
1
Brief Summary
This study is a prospective observational cohort study of 6 and 12 months long-term outcome of Danish speaking patients with COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedFirst Posted
Study publicly available on registry
June 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedJune 2, 2021
June 1, 2021
8 months
February 4, 2021
June 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The cognitive status at 6 and 12 months after ICU admission using the validated instrument MiniMoCA
The cognitive status at 6 and 12 months after ICU admission using the validated instrument MiniMoCA. Score 0-15, score above 11 indicate normal cognitive function. Two time points to see if there is a change in the cognitive status over time.
at 6 and 12 months after ICU admission
The functional status at 6 and 12 months after ICU admission using the validated instrument CFS
The functional status at 6 and 12 months after ICU admission using the validated instrument CFS (score 1-9) higher levels indicate more frailty. Two time points to see if there is a change in the frailty status over time.
at 6 and 12 months after ICU admission
Secondary Outcomes (7)
The association between ventilator days and CFS 6 and 12 months after ICU admission
at 6 and 12 months after ICU admission
The association between ventilator days and MiniMoCA 6 and 12 months after ICU admission
at 6 and 12 months after ICU admission
Mortality 6 and 12 months after ICU admission
at 6 and 12 months after ICU admission
EQ-5D-5L score 6 and 12 months after ICU admission
at 6 and 12 months after ICU admission
Barthel ADL score 6 and 12 months after ICU admission
at 6 and 12 months after ICU admission
- +2 more secondary outcomes
Eligibility Criteria
The study population is all Danish speaking COVID-19 patients, admitted and treated at one of the 29 Danish ICUs, and enrolled in the 'Danish ICU COVID-19 database' from March 10th and forward. Patients are 18 of age and above with a positive polymerase chain reaction (PCR) test for SARS-CoV-2 either prior to or during ICU admission
You may qualify if:
- \> 18 years
- enrolled in the 'Danish ICU COVID-19 database'
You may not qualify if:
- non danish speaking patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anaesthesiology
Køge, 4600, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lone Poulsen, MD
Department of Anaesthesiology and Intensive Care
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2021
First Posted
June 2, 2021
Study Start
October 1, 2020
Primary Completion
June 1, 2021
Study Completion
September 1, 2021
Last Updated
June 2, 2021
Record last verified: 2021-06